Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML clinical trial (NCT02306291). Contact the study team or your healthcare provider for specific answers.

Question 2

How does GMI-1271 compare to other treatments I might be considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML clinical trial (NCT02306291). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of GMI-1271 and the chemotherapy drugs used in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML clinical trial (NCT02306291). Contact the study team or your healthcare provider for specific answers.

Question 4

How often would I need to come in for treatments and check-ups if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML clinical trial (NCT02306291). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML clinical trial (NCT02306291). Contact the study team or your healthcare provider for specific answers.

Question 6

How will this trial fit into my overall treatment plan for AML?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML clinical trial (NCT02306291). Contact the study team or your healthcare provider for specific answers.

What this study is about